IMPAC CORPORATION – Trademark Portfolio

Entity Type: 03

IMPAC CORPORATION has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 67% registration rate. The portfolio includes marks such as SOF SOLE and THERAPY EDGE. Filings span 3 Nice Classification classes, with the highest activity in Class 25 (Clothing) and Class 10 (Medical Apparatus). This trademark owner is based in DURHAM, NC.

FIVE OAKS OFFICE PARK

4905 PINE CONE DRIVE

DURHAM, NC 27707

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

IMPAC CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does IMPAC CORPORATION have?

IMPAC CORPORATION has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.

What trademark classes does IMPAC CORPORATION file in?

IMPAC CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 25 covers clothing, footwear, headgear.

What are IMPAC CORPORATION's most well-known trademarks?

IMPAC CORPORATION's registered trademark portfolio includes well-known marks such as SOF SOLE and THERAPY EDGE. These are among 2 currently registered trademarks in the portfolio.

What is IMPAC CORPORATION's trademark registration success rate?

IMPAC CORPORATION has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.